Breaking Finance News

STERIS plc Ordinary Shares (NYSE:STE) has been upgraded to Hold in a statement by Zacks Investment Research earlier today.

Having a price of $72.96, STERIS plc Ordinary Shares (NYSE:STE) traded -0.36% lower on the day. With the last stock price up 3.87% from the two hundred day average, compared with the Standard & Poor's 500 Index which has decreased -0.01% over the same period. STE has recorded a 50-day average of $71.26 and a two hundred day average of $70.18. Trade Volume was down over the average, with 109,624 shares of STE changing hands under the typical 531,630

Zacks Investment Research has upgraded STERIS plc Ordinary Shares (NYSE:STE) to Hold in a statement released on 9/29/2016.

Recent Performance Chart

STERIS plc Ordinary Shares (NYSE:STE)

With a total market value of $0, STERIS plc Ordinary Shares has price-earnings ratio of 41.87 with a one year low of $61.38 and a one year high of $78.77 .

A total of 6 analysts have released a report on the company. 2 brokers rating the stock a strong buy, 3 brokers rating the stock a buy, two equity analysts rating the company a hold, zero equity analysts rating the company a underperform, and finally zero equity analysts rating the company a sell with a one year target of $86.33.

Brief Synopsis About STERIS plc Ordinary Shares (NYSE:STE)

STERIS plc develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support products and services for healthcare, pharmaceutical, scientific, research, industrial, and governmental customers worldwide. Its Healthcare Products segment offers steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers, as well as liquid chemical sterilant processing systems; automated washer/disinfector systems; general and specialty surgical tables, surgical and examination lights, equipment management systems, operating room storage cabinets, warming cabinets, scrub sinks, and other accessories; and gastrointestinal devices and accessories. This segment also provides OR integration, OR and sterile processing department, workflow, patient tracking, and instrument management solutions; cleaning chemistries and sterility assurance products; and hard surface disinfectants, skin care, and hand hygiene solutions. In addition, it offers preventive maintenance and repair, sterilization and surgical management consulting, and remote equipment monitoring services, as well as other support services. The companyÂ’s Healthcare Specialty Services segment offers instrument and endoscope repair and maintenance solutions; on site and off site reprocessing surgical instruments, as well as custom process consulting; and outsourced linen rental, reprocessing, and managed supply chain solutions. Its Life Sciences segment offers formulated cleaning chemistries, vaporized hydrogen peroxide generators, high-purity water equipment, steam sterilizers, and washers/disinfectors. The companyÂ’s Applied Sterilization Technologies segment provides contract sterilization services using gamma, electron beam, and X-ray technologies, as well as ethylene oxide gas; and laboratory testing and validation services. It operates a network of 59 facilities. STERIS plc was founded in 1985 and is headquartered in Leicester, the United Kingdom.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.